AZP-3601 SAD and MAD Study in Healthy Subjects and Patients With Hypoparathyroidism

NCT05239221 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hypoparathyroidism

Interventions

DRUG: AZP-3601
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]